
Health Frequency Inc
Health Frequency Inc. Restoring Cellular Perfusion by Neutralizing Material Interference. Environmental Biocompatibility: The Key to Health and Longevity.
Brooklyn, NY, US (United States)
Developing non-invasive biophysical solutions to eliminate microvascular hypoxia and restore cellular longevity through environmental biocompatibility.
Health Frequency Inc hero image
Close

How We Help
Photos & Videos
Dynamic Infrared Thermography: Microvascular Reperfusion via Biocompatible Interface Real-time recording via FLIR ThermaCAM™ demonstrates rapid reversal of peripheral microvascular vasospasm in a female subject with chronic circulatory impairment. Contact application of the patented Health Frequency® biocompatible alloy interface (U.S. Patent No. 2013/0259736) restored terminal capillary perfusion, driving a temperature increase of >15°F (>8.3°C) within 30 minutes by neutralizing boundary dielectric stress.
Problem Statement
Continuous dielectric and ambient electrodynamic stress from bio-incompatible everyday contact materials induces persistent microvascular vasospasms, directly suppressing terminal capillary perfusion and destabilizing peripheral thermoregulation. This physical barrier restricts cellular oxygen delivery and impairs mitochondrial bioenergetics. Conventional longevity interventions focus strictly on secondary biochemical symptoms, leaving this primary environmental trigger completely unaddressed.
Core Technology
Patented biocompatible metal alloys (U.S. Patent No. 2013/0259736).
Key Differentiators
Patented core alloy formula (U.S. Patent No. 2013/0259736), first-mover advantage in ambient wave neutralization applied directly to microvascular homeostatic textiles, high barrier to entry due to deep-tech metallurgical composition and specialized integration process, and rigorous empirical thermographic and cellular research.
Clinical Focus
Microvascular circulation, mitochondrial efficiency, thermoregulation, cellular longevity, physiological homeostasis.
Target Customers
Health-conscious high-net-worth individuals, longevity enthusiasts, biohackers, preventive health practitioners, premium apparel and wellness brands, research institutes, longevity clinics, and bio-protection organizations.
Product Stage
Prototype
Company Info
- Business Model
- D2C, B2B Licensing, Institutional Partnerships
- Website
- healthfrequency.com
Disease Areas
Technologies
Clinical & IP
Clinical Validation
Immediate restoration of microcirculation and thermal regulation demonstrated by thermographic imaging, showing measurable heat redistribution and increased peripheral vascular perfusion. Sustained stabilization of tissue temperature without active external heat sources. Built on Glen Rein's scientific foundation on ambient wave interference and mitochondrial response. Further clinical/empirical biomarker studies are underway.
IP Protection
Granted U.S. Patent No. 2013/0259736 for core alloy composition. Robust international patent strategy protecting core alloy composition and integration methods.
Only accessible to MedStartr community members.
Join nowWhat do you think of Health Frequency Inc?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
